AC
Acrivon Therapeutics, Inc. Common Stock (ACRV)
NASDAQ·Healthcare·Biotechnology
$1.50
+4.17%
Mkt Cap $59.33M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (11 analysts)
$21.83
Range $17.00 – $30.00
Implied Upside
+1355.3%
Consensus $21.83 vs current $1.50